Intra-Cellular Therapies Stock Surges After J&J Agrees to Buy Drug Maker
Intra-Cellular Therapies (ITCI) stock rose more than 35% premarket after Johnson & Johnson (JNJ) agreed to buy the biopharmaceutical company for $132 a share. Read more: ...
Stock Market Today: S&P 500 Futures Fall, Bond Yields Gain
Live updates on stocks and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.
Shake Shack Aims to Add Hundreds of Burger Shops
Americans will have more opportunities to eat ShackBurgers in coming years, as fast-casual chain Shake Shack plans to more ...
Macy's Warns of Weak Holiday Sales
Macy’s warned of weaker revenue in the crucial year-end period, saying net sales will likely come in at the low end or slightly below its previously guided range of $7.8 billion to $8 billion.